Strategy
MSTR
NVIDIA
NVDA
Meta Platforms
META
Oracle
ORCL
Amazon
AMZN
US Stock MarketDetailed Quotes
IONS Ionis Pharmaceuticals
- 31.760
- -0.090-0.28%
Close Feb 26 16:00 ET
- 31.760
- 0.0000.00%
Post 20:01 ET
5.05BMarket Cap-10.45P/E (TTM)
32.850High31.420Low1.46MVolume32.070Open31.850Pre Close46.64MTurnover0.93%Turnover RatioLossP/E (Static)158.96MShares52.34052wk High8.58P/B5.01BFloat Cap30.23052wk Low--Dividend TTM157.59MShs Float86.582Historical High--Div YieldTTM4.49%Amplitude2.500Historical Low31.996Avg Price1Lot Size
About Ionis Pharmaceuticals Company
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Company Profile
SymbolIONS
Company NameIonis Pharmaceuticals
Listing DateApr 17, 1991
Issue Price57.56
Founded1989
CEODr. Brett P. Monia, PhD
MarketNASDAQ
Employees1069
Fiscal Year Ends12-31
Address2855 Gazelle Court
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92010
Phone1-760-931-9200
Websitehttp://www.ionis.com
Company Executives
- Name
- Position
- Salary
- Dr. Brett P. Monia, PhD
- Chief Executive Officer and Director
- 12.50M
- Eugene Schneider
- Executive Vice President and Chief Clinical Development and Operations Officer
- --
- Shannon L. Devers
- Executive Vice President and Chief Human Resources Officer
- --
- Elizabeth L. Hougen
- Executive Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
- 2.89M
- Dr. Richard S. Geary,PhD
- Executive Vice President and Chief Development Officer
- 2.56M
- Kyle Jenne
- Executive Vice President and Chief Global Product Strategy Officer
- --
- Dr. C. Frank Bennett,PhD
- Executive Vice President and Chief Scientific Officer
- --
- Patrick R. O'Neil, Esq.
- Executive Vice President, Chief Legal Officer, General Counsel and Corporate Secretary
- --
- Joseph T. Baroldi
- Executive Vice President and Chief Business Officer
- --
- Brian Birchler
- Executive Vice President, Corporate and Development Operations
- --
- Eric E. Swayze, PhD
- Executive Vice President, Research
- 2.56M
- Dr. Joseph Loscalzo, M.D.,PhD
- Chairman of the Board
- 568.04K
- B. Lynne Parshall, Esq.,J.D.
- Director
- 538.04K
- Dr. Michael Hayden
- Independent Director
- 528.04K
- Joseph H. Wender
- Lead Independent Director
- 598.04K
- Joan E. Herman
- Independent Director
- 540.04K
- Allene M. Diaz
- Independent Director
- 530.04K
- Joseph Klein, III
- Independent Director
- 542.04K
- Dr. Spencer R. Berthelsen,M.D.
- Independent Director
- 548.04K
- Michael J. Yang
- Independent Director
- 363.05K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.